Basic information
- Standard SMILES
NCCCCC(=O)O- InChIKey
JJMDCOVWQOJGCB-UHFFFAOYSA-N- Molecular formula
- C5H11NO2
- Average molar mass
- 117.15 g/mol
- Monoisotopic mass
- 117.07897859
Overview
5-aminopentanoic acid is a delta-amino acid comprising pentanoic acid with an amino substituent at C-5; a methylene homologue of gamma-aminobutyric acid (GABA) that is a weak GABA agonist. It has a role as a human metabolite. It is a delta-amino acid and an omega-amino fatty acid. It is functionally related to a valeric acid. It is a conjugate acid of a 5-aminopentanoate. It is a tautomer of a 5-aminopentanoic acid zwitterion.
Names & identifiers
- Preferred name
- 5-Aminovaleric acid
- IUPAC
- 5-aminopentanoic acid
- English name
- 5-Aminovaleric acid
- Molecular formula
- C5H11NO2
- Molecular weight
- 117.15
Names & synonyms
Show more names
Database identifiers
- CAS
660-88-8- PubChem CID
- 138
- DTXSID
DTXSID70216212- ChEMBL
CHEMBL284116- ChEBI
CHEBI:15887- UNII
- BUW4BFJ6SC
- EC Number
- 211-544-5
- Nikkaji
- J38.132B
Properties
Computed structural properties
- XLogP
- -2.6
- Topological polar surface area
- 63.3 Ų
- Hydrogen bond donors
- 2
- Hydrogen bond acceptors
- 3
- Rotatable bonds
- 4
- Heavy atoms
- 8
- Formal charge
- 0
- Complexity
- 72.8
Experimental & physicochemical properties
Physicochemical properties
- Melting point
- 158 · 158-161 °C(lit.)
- Boiling point
- 247.5 · 247.5±23.0 °C(Predicted)
- Density
- 1.2 · 1.2000 (estimate)
- refractive index
- 1.465 · 1.4650 (estimate)
- storage temp.
- Sealed in dry,Room Temperature
- solubility
- Chloroform (Slightly), Methanol (Slightly), Water (Slightly)
- form
- Crystalline Powder
- pka
- 4.27 · 4.27(at 25℃)
- color
- White to off-white
- BRN
- 906833 · 906833
- Major Application
- peptide synthesis
- InChI
- InChI=1S/C5H11NO2/c6-4-2-1-3-5(7)8/h1-4,6H2,(H,7,8)
- InChIKey
- JJMDCOVWQOJGCB-UHFFFAOYSA-N
- SMILES
- C(O)(=O)CCCCN
- CAS DataBase Reference
- 660 · 660-88-8(CAS DataBase Reference)
- UNSPSC Code
- 12352106 · 12352106
- NACRES
- 22 · NA.22
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 315 · H315-H319-H335
- Precautionary statements
- 261 · P261-P305+P351+P338
- PPE
- 95 · Eyeshields, Gloves, type N95 (US)
- Hazard Codes
- Xn
- Risk Statements
- 20 · 20/21/22-36/37/38
- Safety Statements
- 22 · 22-24/25-36-26
- WGK Germany
- 3 · 3
- HS Code
- 29224999 · 29224999
- Storage Class
- 11 · 11 - Combustible Solids
Safety & regulation
GHS classification
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Hazard information
Safety data
- PPE
- Eyeshields, Gloves, type N95 (US)
- wgk
- 3
- hs_code
- 29224999
- risk_code
- 20/21/22-36/37/38
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- hazard_code
- Xn
- safety_code
- 22-24/25-36-26
- Storage Class
- 11 - Combustible Solids
- Hazard statements
- H315-H319-H335
- Precautionary statements
- P261-P305+P351+P338
Chemistry & industry
Pharmacology
Applications
Uses5-Aminovaleric acid (5-AVA) is used:In the preparation of (5-AVA)x(MA)1-xPbI3, a perovskite for fabricating printable mesoscopic perovskite solar cell.As a spacer in the synthesis of rhenium and technetium-99m labeled insulin.To synthesize dipeptides that self-assemble to form nanotubes in the solid state as well as in solution over a wide range of pH.As a starting material in the total synthesis of an alkaloid, lycoposerramine Z.
Uses5-Aminovaleric Acid is used in the development of drugs that halts severe type of seizures.
Upstream & downstream products
Downstream products
Suppliers50 total
Additional notes
DefinitionChEBI: A delta-amino acid comprising pentanoic acid with an amino substituent at C-5; a methylene homologue of gamma-aminobutyric acid (GABA) that is a weak GABA agonist.
Related reactions
Linked notes
Loading…